68 related articles for article (PubMed ID: 17095615)
1. Marked insulin resistance in obese spontaneously hypertensive rat adipocytes is ameliorated by in vivo but not in vitro treatment with moxonidine.
Sun Z; Ernsberger P
J Pharmacol Exp Ther; 2007 Feb; 320(2):845-52. PubMed ID: 17095615
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
3. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.
Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P
Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453
[TBL] [Abstract][Full Text] [Related]
4. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.
Velliquette RA; Ernsberger P
J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
Ernsberger P; Koletsky RJ; Collins LA; Bedol D
Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
Ernsberger P; Koletsky RJ; Friedman JE
Ann N Y Acad Sci; 1999 Nov; 892():272-88. PubMed ID: 10842668
[TBL] [Abstract][Full Text] [Related]
7. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat.
Friedman JE; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Kaung HL; Ernsberger P
Am J Physiol; 1997 Nov; 273(5):E1014-23. PubMed ID: 9374689
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P
J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894
[TBL] [Abstract][Full Text] [Related]
9. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats.
Henriksen EJ; Jacob S; Fogt DL; Youngblood EB; Gödicke J
Hypertension; 1997 Dec; 30(6):1560-5. PubMed ID: 9403583
[TBL] [Abstract][Full Text] [Related]
11. Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X.
Velliquette RA; Koletsky RJ; Ernsberger P
Exp Biol Med (Maywood); 2002 Mar; 227(3):164-70. PubMed ID: 11856814
[TBL] [Abstract][Full Text] [Related]
12. Imidazoline receptors but not alpha 2-adrenoceptors are regulated in spontaneously hypertensive rat heart by chronic moxonidine treatment.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
J Pharmacol Exp Ther; 2004 Aug; 310(2):446-51. PubMed ID: 15075383
[TBL] [Abstract][Full Text] [Related]
13. Cardiac effects of moxonidine in spontaneously hypertensive obese rats.
Mukaddam-Daher S; Menaouar A; El-Ayoubi R; Gutkowska J; Jankowski M; Velliquette RA; Ernsberger P
Ann N Y Acad Sci; 2003 Dec; 1009():244-50. PubMed ID: 15028594
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB).
Ishizuka T; Ernsberger P; Liu S; Bedol D; Lehman TM; Koletsky RJ; Friedman JE
J Nutr; 1998 Dec; 128(12):2299-306. PubMed ID: 9868173
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II enhances insulin sensitivity in vitro and in vivo.
Juan CC; Chien Y; Wu LY; Yang WM; Chang CL; Lai YH; Ho PH; Kwok CF; Ho LT
Endocrinology; 2005 May; 146(5):2246-54. PubMed ID: 15705782
[TBL] [Abstract][Full Text] [Related]
16. Norepinephrine- and insulin-resistant glucose transport in brown adipocytes from diabetic SHR/N-cp rats.
Marette A; Mauriège P; Després JP; Tulp OL; Bukowiecki LJ
Am J Physiol; 1993 Sep; 265(3 Pt 2):R577-83. PubMed ID: 8214149
[TBL] [Abstract][Full Text] [Related]
17. Two triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activation.
Zhu KN; Jiang CH; Tian YS; Xiao N; Wu ZF; Ma YL; Lin Z; Fang SZ; Shang XL; Liu K; Zhang J; Liu BL; Yin ZQ
Phytomedicine; 2015 Aug; 22(9):837-46. PubMed ID: 26220631
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
[TBL] [Abstract][Full Text] [Related]
19. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes.
Zhao L; Hu P; Zhou Y; Purohit J; Hwang D
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E587-98. PubMed ID: 21693690
[TBL] [Abstract][Full Text] [Related]
20. Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects.
Sajan MP; Standaert ML; Miura A; Bandyopadhyay G; Vollenweider P; Franklin DM; Lea-Currie R; Farese RV
J Clin Endocrinol Metab; 2004 Aug; 89(8):3994-8. PubMed ID: 15292339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
